LSE:HEMO   HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
Massive winner today Hemogenyx (HEMO) moved 55% in 1.5h before market close on the news drop of working closely and in agreement with Eli Lilly. The correction has been clearly completed and there were already signs of this impulse up with the sub wave 1 and then sub wave 2 correction days ago. The larger Wave 2 is complete already and we are in the most bullish phase now.
Targets are marked for the wave 3 upside, of course it can extend well further than the conservative targets of 1:1 and x1.618 extension only.
Hemo is working closely so far with 2 giant Pharma companies. Their research is truly significant and has a massive potential in their future value.
The mcap is well undervalued on this future potential and on the recent news.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。